Literature DB >> 10534628

Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature.

S Akhtar1, K K Oza, S A Khan, J Wright.   

Abstract

BACKGROUND: Muir-Torre syndrome is a rare autosomal dominant genodermatosis, first described in 1967, characterized by the presence of sebaceous tumors and an internal malignancy in the absence of other predisposing factors.
OBJECTIVE: Our purpose was to review and update published literature on Muir-Torre syndrome.
METHODS: We describe a 66-year-old white man with a history of sebaceous tumors and newly diagnosed transitional cell cancer of the right ureter and adenocarcinoma of the jejunum. The literature on Muir-Torre syndrome is reviewed by means of MEDLINE search and available published reports and updated.
RESULTS: Only 205 cases of Muir-Torre syndrome with 399 internal malignancies have been reported. The common presentation is the presence of sebaceous tumors along with a low-grade visceral malignancy. Sebaceous tumors appeared before the internal malignancy in 45 cases (22%), concurrently in 12 (6%), and after the internal malignancy in 114 (56%). In 33 (16%) of 205 patients, a temporal relationship was not reported. The total number of sebaceous gland carcinomas reported is 44; 17 of 44 were neoplasms of the meibomian gland. Keratoacanthomas have been noted in 48 (23%) of 205 patients. Gastrointestinal cancers are the most common internal malignancies (61%), followed by genitourinary (22%).
CONCLUSION: The presence of sebaceous tumors warrants a search for an internal malignancy. In patients with Muir-Torre syndrome, regular follow-up and search for new malignancy is mandatory. Evaluation and monitoring of the family members of patients are also necessary. Patients and their families should be counseled for genetic testing. Genetic analysis of the primary tumor and skin lesions should be arranged as an added research tool if possible to better understand the disease.

Entities:  

Mesh:

Year:  1999        PMID: 10534628     DOI: 10.1016/s0190-9622(99)70001-0

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  31 in total

Review 1.  Cutaneous manifestations of cancer and chemotherapy.

Authors:  Emma Topham
Journal:  Clin Med (Lond)       Date:  2009-08       Impact factor: 2.659

2.  [Recurrent eyelid tumors with different dignities].

Authors:  U Löw; C S L Müller; E Zemova; F A Flockerzi; B Seitz
Journal:  Ophthalmologe       Date:  2019-11       Impact factor: 1.059

3.  Defective DNA mismatch repair activity is common in sebaceous neoplasms, and may be an ineffective approach to screen for Lynch syndrome.

Authors:  Anu R Lamba; Angela Y Moore; Todd Moore; Jennifer Rhees; Mildred A Arnold; C Richard Boland
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

4.  Skin lesions with Lynch syndrome could represent Muir-Torre syndrome.

Authors:  Nauman Siddiqui; Zeeshan Tariq; Colette Gaba; Danae Hamouda; Ali Nawras; Shahnaz Ul Rehman; Iman E Mohamed
Journal:  Int J Colorectal Dis       Date:  2014-05-03       Impact factor: 2.571

5.  Lynch syndrome with exclusive skin involvement: time to consider a molecular definition?

Authors:  Alessandro Vaisfeld; Martina Calicchia; Maria Grazia Pomponi; Emanuela Lucci-Cordisco; Luca Reggiani-Bonetti; Maurizio Genuardi
Journal:  Fam Cancer       Date:  2019-10       Impact factor: 2.375

6.  The liver: another organ involved in Muir Torre syndrome?

Authors:  F Morando; M Alaibac; A Romano; M Cavallin; S Piano; M Pizzi; C Mescoli; P Pilati; A Gatta; P Angeli
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

7.  Ovarian Sex-cord Tumour with Peutz-Jeghers Polyp and Giant Keratoacanthoma.

Authors:  S K Magu; A K Malaviya; A K Behl; A Basu
Journal:  Med J Armed Forces India       Date:  2011-07-21

8.  [Muir-Torre syndrome with previously undescribed frameshift mutation in the MSH2 gene].

Authors:  B Gilly; A Unholzer; G Strobl-Wildemann; C Haas; H Starz; J Welzel
Journal:  Hautarzt       Date:  2013-04       Impact factor: 0.751

9.  Muir-Torre syndrome: a case report and screening recommendations.

Authors:  A Pancholi; D Collins; R Lindley; P Gandhi
Journal:  Ann R Coll Surg Engl       Date:  2008-11       Impact factor: 1.891

Review 10.  Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation.

Authors:  Iyer Vishwas Neelakantan; Silvana Di Palma; C E T Smith; A McCoombe
Journal:  Head Neck Pathol       Date:  2015-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.